, Ortho Dermatologics, Bridgewater, NJ
-
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Acne-Related Quality of Life: Efficacy of a Novel Tretinoin 0.05% Lotion in Male and Female Patients with Moderate-to-Severe Disease
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Acne-Related Quality of Life: Correlation Between Acne Symptom Scores and Other Domains Following Treatment with Tretinoin 0.05% Lotion
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast)
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Optimized Formulation for Topical Application of a Fixed Combination Halobetasol/Tazarotene Lotion Using Polymeric Emulsion Technology
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower Extremities
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®) - Acne & Rosacea
Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Acne & Rosacea
A Randomized, Observer‑Blind, Split‑Face Study to Assess Compatibility of Facial Foundation Makeup with Tretinoin 0.05% Lotion and Skin Texture After Application
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Patients With Psoriasis Treated With Brodalumab: A Pooled Post Hoc Analysis of a Marker of Liver Inflammation in Individuals With Potential Indicators of Early Nonalcoholic Fatty Liver Disease
Abstract Poster PDF -
SKIN The Journal of Cutaneous Medicine Vol. 3 (2019): Supplemental Issue: Scientific Posters Presented at 2019 Fall Clinical Dermatology Conference®-Las Vegas - Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Long-term Efficacy and Safety of Brodalumab in Patients With or Without History of Psoriatic Arthritis: Analysis of Two Phase 3 Psoriasis Studies
Abstract Poster PDF